159 related articles for article (PubMed ID: 37069584)
21. Clinical Significance of Preoperative Serum Carcinoembryonic Antigen Within the Normal Range in Colorectal Cancer Patients Undergoing Curative Resection.
Beom SH; Shin SJ; Kim CG; Kim JH; Hur H; Min BS; Lee KY; Kim NK; Ahn JB
Ann Surg Oncol; 2020 Aug; 27(8):2774-2783. PubMed ID: 32180063
[TBL] [Abstract][Full Text] [Related]
22. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
23. The Changes and Clinical Significance of Preoperative and Postoperative Serum CEA and CA19-9 in Gastric Cancer.
Jing R; Cui M; Ju S; Pan S
Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255307
[TBL] [Abstract][Full Text] [Related]
24. The Prognostic Relevance of Preoperative CEA and CA19-9 for Ampulla of Vater Carcinoma.
Matsui S; Yamamoto Y; Okamura Y; Ito T; Ashida R; Ohgi K; Yamada M; Otsuka S; Uesaka K; Sugiura T
Anticancer Res; 2022 Jun; 42(6):3169-3176. PubMed ID: 35641260
[TBL] [Abstract][Full Text] [Related]
25. The Prognostic Value of Preoperative Serum CEA and CA19-9 Values in Stage I-III Colorectal Cancer.
Wang RF; Song BR; Peng JJ; Cai GX; Liu FQ; Wang MH; Cai SJ; Ye X
Hepatogastroenterology; 2014 Jun; 61(132):994-9. PubMed ID: 26158155
[TBL] [Abstract][Full Text] [Related]
26. Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer.
Ishigami S; Natsugoe S; Hokita S; Che X; Tokuda K; Nakajo A; Iwashige H; Tokushige M; Watanabe T; Takao S; Aikou T
J Clin Gastroenterol; 2001 Jan; 32(1):41-4. PubMed ID: 11154168
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors in patients undergoing complete resection of pulmonary metastases of colorectal cancer: a multi-institutional cumulative follow-up study.
Hirosawa T; Itabashi M; Ohnuki T; Yamaguchi N; Sugihara K; Kameoka S;
Surg Today; 2013 May; 43(5):494-9. PubMed ID: 23085967
[TBL] [Abstract][Full Text] [Related]
28. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?
Morita S; Nomura T; Fukushima Y; Morimoto T; Hiraoka N; Shibata N
Dis Colon Rectum; 2004 Feb; 47(2):227-32. PubMed ID: 15043294
[TBL] [Abstract][Full Text] [Related]
29. Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study.
Li C; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T
EBioMedicine; 2021 Dec; 74():103706. PubMed ID: 34801967
[TBL] [Abstract][Full Text] [Related]
30. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
31. Preoperative CA19-9: a competitive predictor of recurrence in patients with colorectal cancer liver metastases after hepatectomy.
Liu JM; Wang YY; Liu W; Xu D; Wang K; Xing BC
Int J Colorectal Dis; 2021 Apr; 36(4):767-778. PubMed ID: 33420522
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of serum CEA, CA19-9 and CA125 in diagnosis of colorectal liver metastasis in Chinese population.
Zhang D; Yu M; Xu T; Xiong B
Hepatogastroenterology; 2013 Sep; 60(126):1297-301. PubMed ID: 23933921
[TBL] [Abstract][Full Text] [Related]
33. The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment.
Tokunaga R; Sakamoto Y; Nakagawa S; Yoshida N; Baba H
Surg Today; 2017 May; 47(5):636-642. PubMed ID: 28062920
[TBL] [Abstract][Full Text] [Related]
34. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
Bakalakos EA; Burak WE; Young DC; Martin EW
Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
[TBL] [Abstract][Full Text] [Related]
35. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.
Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C
Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125
[TBL] [Abstract][Full Text] [Related]
36. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis.
Hohenberger P; Schlag PM; Gerneth T; Herfarth C
Ann Surg; 1994 Feb; 219(2):135-43. PubMed ID: 8129484
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative Treatment.
Kobayashi K; Ono Y; Kitano Y; Oba A; Sato T; Ito H; Mise Y; Shinozaki E; Inoue Y; Yamaguchi K; Saiura A; Takahashi Y
Ann Surg Oncol; 2023 Nov; 30(12):7338-7347. PubMed ID: 37365416
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Reappraisal of Postoperative Carcinoembryonic Antigen in T1-2N0 Colorectal Cancer.
Pian G; Shin JS; Yoon S; Oh SY
Anticancer Res; 2021 Feb; 41(2):1101-1110. PubMed ID: 33517321
[TBL] [Abstract][Full Text] [Related]
39. [Diagnostic value of
Zhang XC; Zhang JH; Wang RF; Fan Y; Fu ZL; Yan P; Zhao GY; Bai YX
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1071-1077. PubMed ID: 31848507
[TBL] [Abstract][Full Text] [Related]
40. Repeat resection of pulmonary metastasis is beneficial for patients with colorectal carcinoma.
Chen F; Sakai H; Miyahara R; Bando T; Okubo K; Date H
World J Surg; 2010 Oct; 34(10):2373-8. PubMed ID: 20582543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]